Skip to content
GenoLensGenoLens

PMVK

Chr 1q21.3

phosphomevalonate kinase

Aliases:
PMK, PMKA, HUMPMKI
MANE:
ENST00000368467.4

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Moderate Evidence (Amber)

  • Mosaic skin disorders - deep sequencing

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • Rare genetic inflammatory skin disorders

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • Familial disseminated superficial actinic porokeratosis

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Pigmentary skin disorders

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Disease associations (Open Targets)

  • porokeratosis 1, Mibelli type

    0.64
  • neurodegenerative disease

    0.53
  • porokeratosis

    0.42
  • porokeratosis of Mibelli

    0.37
  • linear porokeratosis

    0.35
  • functional neutrophil defect

    0.31
  • hereditary disease

    0.19
  • atrial fibrillation

    0.12
  • osteoarthritis, knee

    0.10
  • total knee arthroplasty

    0.10

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Phosphomevalonate kinase

Catalyzes the reversible ATP-dependent phosphorylation of mevalonate 5-phosphate to produce mevalonate diphosphate and ADP, a key step in the mevalonic acid mediated biosynthesis of isopentenyl diphosphate and other polyisoprenoid metabolites

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.